Microglial activation induced by neurodegeneration: A proteomic analysis

Molecular and Cellular Proteomics

Volumn 4, Issue 10, 2005, Pages 1471-1479

  Zhou, Yong ^a   Wang, Yan ^a   Kovacs, Monica ^a   Jin, Jinghua ^a   Zhang, Jing ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; AMINO ACID; CARBAMIC ACID DERIVATIVE; PROTEOME;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CELL CULTURE; CELL FRACTIONATION; CELL INTERACTION; CELL LINE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ISOTOPE LABELING; MICROGLIA; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ETHYLENEBIS(DITHIOCARBAMATES); MEMBRANE PROTEINS; MICROGLIA; NERVE DEGENERATION; NEURONS; NEUROTOXICITY SYNDROMES; ORGANOMETALLIC COMPOUNDS; PROTEOME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; PARKINSONIA;

EID: 27644559809     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M500114-MCP200     Document Type: Article

References (42)

1. Liu, B., and Hong, J. S. (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol. Exp. Ther. 304, 1-7
2. McGeer, P. L., and McGeer, E. G. (1998) Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis. Assoc. Disord. 12, S1-S6
3. Orr, C. F., Rowe, D. B., and Halliday, G. M. (2002) An inflammatory review of Parkinson's disease. Prog. Neurobiol. 68, 325-340
4. Liu, B., Gao, H. M., and Hong, J. S. (2003) Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ. Health Perspect. 111, 1065-1073
5. Bronstein, D. M., Perez-Otano, I., Sun, V., Mullis Sawin, S. B., Chan, J., Wu, G. C., Hudson, P. M., Kong, L. Y., Hong, J. S., and McMillian, M. K. (1995) Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res. 704, 112-116
6. Gao, H. M., Jiang, J., Wilson, B., Zhang, W., Hong, J. S., and Liu, B. (2002) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81, 1285-1297
7. Gao, H. M., Hong, J. S., Zhang, W., and Liu, B. (2002) Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 22, 782-790
8. Qin, L., Liu, Y., Cooper, C., Liu, B., Wilson, B., Hong, J. S., Wilson, B. C., and An, L. (2002) Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem. 83, 973-983
9. Cicchetti, F., Brownell, A. L., Williams, K., Chen, Y. I., Livni, E., and Isacson, O. (2002) Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur. J. Neurosci. 15, 991-998
10. Carvey, P. M., Chang, Q., Lipton, J. W., and Ling, Z. (2003) Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front. Biosci. 8, s826-s837
11. Ferraz, H. B., Bertolucci, P. H., Pereira, J. S., Lima, J. G., and Andrade, L. A. (1988) Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 38, 550-553
12. Meco, G., Bonifati, V., Vanacore, N., and Fabrizio, E. (1994) Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). Scand. J. Work Environ. Health. 20, 301-305
13. Thiruchelvam, M., Brockel, B. J., Richfield, E. K., Baggs, R. B., and Cory-Slechta, D. A. (2000) Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res. 873, 225-234
14. Zhang, J., Fitsanakis, V., Gu, G., Jing, D., Ao, M., Amamath, V., and Montine, T. (2003) Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J. Neurochem. 84, 1-11
15. Zhou, Y., Shie, F. S., Piccardo, P., Montine, T. J., and Zhang, J. (2004) Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease. Neuroscience 128, 281-291
16. Zhang, W., Wang, T., Pei, Z., Meng, Y., Wu, X., Belinda, W., Hong, J., and Zhang, J. (2005) α-Synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 19, 533-542
17. Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L., and Lucius, R. (2003) Activation of microglia by human neuromelanin is NF-κB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J. 17, 500-502
18. Aimi, Y., and McGeer, P. L. (1996) Lack of toxicity of human neuromelanin to rat brain dopaminergic neurons. Parkinsonism Relat. Disord. 2, 69-74
19. Cuzner, M. L., Gveric, D., Strand, C., Loughlin, A. J., Paemen, L., Opdenakker, G., and Newcombe, J. (1996) The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55, 1194-1204
20. Shie, F. S., Neely, M. D., Maezawa, I., Wu, H., Olson, S. J., Jurgens, G., Montine, K. S., and Montine, T. J. (2004) Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion. Am. J. Pathol. 164, 1173-1181
21. Liu, B., Qin, L., Yang, S. N., Wilson, B. C., Liu, Y., and Hong, J. S. (2001) Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J. Pharmacol. Exp Ther. 298, 1133-1141
22. Zhou, Y., Gu, G., Goodlett, D. R., Zhang, T., Pan, C., Montine, T. J., Montine, K. S., Aebersold, R. H., and Zhang, J. (2004) Analysis of α-synuclein-associated proteins by quantitative proteomics. J. Biol. Chem. 279, 39155-39164
23. Crawford, G. C., Le, W., Smith, R. G., Xie, W. J., Stefani, E., and Appel, S. H. (1992) A novel N18TG2X mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12, 3392-3398
24. Liu, Y., Qin, L., Wilson, B. C., An, L., Hong, J. S., and Liu, B. (2002) Inhibition by naloxone stereoisomers of β-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J. Pharmacol. Exp. Ther. 302, 1212-1219
25. Suzdak, P. D., Frederiksen, K., Andersen, K. E., Sorensen, P. O., Knutsen, L. J., and Nielsen, E. B. (1992) NNC-711, a novel potent and selective γ-aminobutyric acid uptake inhibitor: pharmacological characterization. Eur. J. Pharmacol. 224, 189-198
26. Mabjeesh, N. J., Frese, M., Rauen, T., Jeserich, G., and Kanner, B. I. (1992) Neuronal and glial γ-aminobutyric acid+ transporters are distinct proteins. FEBS Lett. 299, 99-102
27. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
28. 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). J. Proteome Res. 2, 173-181
29. Le, W., Rowe, D., Xie, W., Ortiz, I., He, Y., and Appel, S. H. (2001) Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J. Neurosci. 21, 8447-8455
30. Zhang, J., Goodlett, D. R., Peskind, E. R., Quinn, J. F., Zhou, Y., Wang, Q., Pan, C., Yi, E., Eng, J., Aebersold, R. H., and Montine, T. J. (2005) Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol. Aging 26, 207-227
31. Jin, J., Meredith, G., Chen, L., Zhou, Y., Xu, J., Yie, F., Lockhart, P., and Zhang, J. (2005) Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Mol. Brain Res. 24, 119-138
32. Gao, H. M., Liu, B., Zhang, W., and Hong, J. S. (2003) Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J. 17, 1954-1956
33. Gao, H. M., Liu, B., Zhang, W., and Hong, J. S. (2003) Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease FASEB J. 17, 1957-1959
34. Barlow, B. K., Lee, D. W., Cory-Slechta, D. A., and Opanashuk, L. A. (2005) Modulation of antioxidant defense systems by the environmental pesticide maneb in dopaminergic cells. Neurotoxicology 26, 63-75
35. Castano, A., Herrera, A. J., Cano, J., and Machado, A. (2002) The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-α, IL-1β and IFN-γ. J Neurochem. 81, 150-157
36. Ling, Z. D., Chang, Q., Lipton, J. W., Tong, C. W., Landers, T. M., and Carvey, P. M. (2004) Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience 124, 619-628
37. Gao, H. M., Hong, J. S., Zhang, W., and Liu, S. (2003) Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease J. Neurosci. 23, 1228-1236
38. Marttila, R. J., and Rinne, U. K. (1977) Disability and progression in Parkinson's disease. Acta Neurol. Scand. 66, 159-169
39. Schwartz, J., and Elizan, T. S. (1979) Search for viral particles, and virus-specific products in idiopathic Parkinson disease brain material. Ann. Neurol. 6, 261-263
40. Christie, R. H., Chung, H., Rebeck, G. W., Strickland, D., and Hyman, B. T. (1996) Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55, 491-498
41. Bai, J., Nakamura, H., Hattori, I., Tanito, M., and Yodoi, J. (2002) Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells. Neurosci. Lett. 321, 81-84
42. 2 in PC12 cells. Arch. Biochem. Biophys. 397, 414-423